Pulmonary nodule characterization: a comparison of conventional with quantitative and visual semi-quantitative analyses using contrast enhancement maps.
暂无分享,去创建一个
Sumit K. Shah | M. McNitt-Gray | D. Aberle | Matthew S. Brown | I. Petkovska | J. Goldin | Hyun J. Kim | K. Brown | M. Brown | Matthew S. Brown
[1] M. Chung,et al. Solitary Pulmonary Nodule : Characterization with Combined Wash-in and Washout Features at Dynamic Multi – Detector Row CT 1 , 2005 .
[2] Sumit K. Shah,et al. Computer aided characterization of the solitary pulmonary nodule using volumetric and contrast enhancement features. , 2005, Academic radiology.
[3] Anne-Marie Sykes,et al. CT screening for lung cancer: five-year prospective experience. , 2005, Radiology.
[4] C. Yi,et al. Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density. , 2004, Radiology.
[5] S. Swensen,et al. Thoracic surgical operations in patients enrolled in a computed tomographic screening trial. , 2004, The Journal of thoracic and cardiovascular surgery.
[6] F. Fazio,et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results , 2003, The Lancet.
[7] P. Choyke,et al. Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.
[8] B. Hillman,et al. Economic, legal, and ethical rationales for the ACRIN national lung screening trial of CT screening for lung cancer. , 2003, Academic radiology.
[9] S. Swensen,et al. Lung cancer screening with CT: Mayo Clinic experience. , 2003, Radiology.
[10] K. Miles,et al. Perfusion CT for the assessment of tumour vascularity: which protocol? , 2003, The British journal of radiology.
[11] W. Heindel,et al. Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers. , 2002, Radiology.
[12] K. Partanen,et al. Reproducibility of scoring emphysema by HRCT: Comparison of visual interpretation methods with pulmonary function tests among farmer's lung patients , 2002 .
[13] S. Swensen,et al. Screening for lung cancer with low-dose spiral computed tomography. , 2000, American journal of respiratory and critical care medicine.
[14] R. Vanninen,et al. Reproducibility of scoring emphysema by HRCT. , 2002, Acta radiologica.
[15] David R. Haynor,et al. Nonrigid multimodality image registration , 2001, SPIE Medical Imaging.
[16] S. Sone,et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner , 2001, British Journal of Cancer.
[17] N. Müller,et al. Lung nodule enhancement at CT: multicenter study. , 2000, Radiology.
[18] J. Hoffman,et al. Tumor angiogenesis: molecular pathology, therapeutic targeting, and imaging. , 2000 .
[19] O. Miettinen,et al. Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.
[20] K. Miles,et al. Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review. , 1999, European journal of radiology.
[21] V. Boyce,et al. Tumor Vasculature: A Potential Therapeutic Target , 1997 .
[22] C. T. Baillie,et al. Tumour vasculature--a potential therapeutic target. , 1995, British Journal of Cancer.
[23] N. Weidner. Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.
[24] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[25] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[26] R K Jain,et al. Determinants of tumor blood flow: a review. , 1988, Cancer research.
[27] Robert M. Haralick,et al. Textural Features for Image Classification , 1973, IEEE Trans. Syst. Man Cybern..
[28] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.